MDoutlook

MDoutlook is a leading precision intelligence company.
We build the success of your organization through better decision-making.

 

Specializing in oncology, hematology, rare and ultra-rare diseases, we answer your business questions with timely precision intelligence using custom marketing research instruments, secondary data sources, our disease access communities – treaters, ThoughtLeaders and other key stakeholders – and our seasoned in-house expertise from across the industry.

Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.

 

Our solutions
MDoutlook provides agile custom and syndicated market research,  secondary data analysis & intelligence, ThoughtLeader identification and network mapping, strategic consulting services and guaranteed physician engagement.

 

Click on the above icons to explore how our clients derive value.

What's New at MDoutlook

Identify rising stars amongst ThoughtLeaders

08 Aug 2019

Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ‘rising stars’ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders…

Read More...

Rapid insights on clinical impact of ASCO – Integration of new treatment regimens in CLL

15 Jul 2019

After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPoll™ study following the 2019 ASCO conference,…

Read More...

Rapid insights on clinical impact of ASCO – Novel Targeted Agents for mNSCLC

11 Jul 2019

After every major conference, MDoutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPoll™ study following the 2019 ASCO conference,…

Read More...

What's Trending in Oncology (updated hourly)